How this AI-based model reads dynamic patient physiology that determines disease trajectory, drug response & toxicity.
Reframing targeted protein measurement from indirect antibody-based approaches to a direct, absolute readout of the key protein.
Covers innate & adaptive immunity, cytokines, chemokines, checkpoints, and cell-death pathways – in a single run.
How our MS-based platform defines a tumor's protein variants in tissue & detects them in blood with high sensitivity.
See how metabolomics screening translates in vitro injury signatures into real patient outcomes.
Directly measure & quantify degradation, selectivity, and mechanism for PROTACs and molecular glues.
A unified system for multi-dimensional measurement of functional biology across 12,000+ proteins in human tumors.
Multi-dimensional proteomic characterization across 15+ normal human tissues to de-risk target selection.
Directly measure proteins that are truly accessible on the tumor cell surface, enabling confident target identification.
Directly measure phosphorylation-driven signaling activity in human tumors to characterize functional pathway activation.
Directly measure immune cell states & signaling pathways in human tumors to characterize immune activity & response.
Directly measure protein networks that drive therapeutic resistance in human tumors to characterize resistance mechanisms.
